CIGA Healthcare
CIGA Healthcare is a British manufacturer of lateral flow assay diagnostic tests.[1] It is under contract to the British government for the supply of AbC-19 rapid antibody tests,[2] a test for the presence of IgG antibody against the SARS-CoV-2 spike protein,[3] as part of the UK Rapid Test Consortium program.[4]
Distribution[edit]
CIGA Healthcare will be responsible[when?] for assembly and distribution of the AbC-19 rapid antibody tests, and has also been awarded distribution in the US after recent FDA approval.[5]
References[edit]
- ^ "Abingdon Health announces its latest expansion and additional manufacturing capacity". Lifescience Industry News. 18 June 2020. Retrieved 12 November 2020.
- ^ "Government invests in UK-developed antibody tests from UK Rapid Test Consortium". GOV.UK. Retrieved 12 November 2020.
- ^ Gill, Dipender; Ponsford, Mark J. (11 November 2020). "Testing for antibodies to SARS-CoV-2". BMJ. 371: m4288. doi:10.1136/bmj.m4288. ISSN 1756-1833. PMID 33315587.
- ^ Symon, Ken (19 October 2020). "Medical diagnostics company signs deal on delivery of Covid-19 tests". businessInsider. Retrieved 12 November 2020.
- ^ "Yorkshire developed Covid-19 test approved for use in North America | TheBusinessDesk.com". Yorkshire. 17 November 2020. Retrieved 13 April 2021.
External links[edit]
 | This article about a company of the UK is a stub. You can help Wikipedia by expanding it. |
 | This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |
 | This article about the COVID-19 pandemic is a stub. You can help Wikipedia by expanding it. |